Evidence map›Paper›PMID 37049659›Full record

ReviewMolecules (Basel, Switzerland)2023

Ángela Suárez-Jacobo, Adrián Díaz Pacheco, Edgar Bonales-Alatorre, Gustavo Adolfo Castillo-Herrera, Jorge Alberto García-Fajardo

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Ángela Suárez-JacoboTecnología Alimentaria, Centro de Investigación y Asistencia en Tecnología y Diseño del Estado de Jalisco, Zapopan 45019, Mexico.ORCID 0000-0003-4143-9557
Adrián Díaz PachecoUnidad Profesional Interdisciplinaria de Ingeniería Campus Tlaxcala del Instituto Politécnico Nacional, Tlaxcala 90000, Mexico.
Edgar Bonales-AlatorreCentro Universitario de Investigaciones Biomédicas, Universidad de Colima, Colima 28045, Mexico.ORCID 0000-0001-6003-8850
Gustavo Adolfo Castillo-HerreraTecnología Alimentaria, Centro de Investigación y Asistencia en Tecnología y Diseño del Estado de Jalisco, Zapopan 45019, Mexico.ORCID 0000-0002-0538-7318
Jorge Alberto García-FajardoSubsede Noreste, Centro de Investigación y Asistencia en Tecnología y Diseño del Estado de Jalisco, Parque de Investigación e Innovación Tecnológica, Apodaca 66628, Mexico.ORCID 0000-0002-8454-2661
Centro de Investigación y Proyectos en Ambiente y Desarrollo · MXInstituto Politécnico Nacional · MXUniversidad de Colima · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Cannabis genus of plants has been widely used in different cultures for various purposes. It is separated into three main species: sativa, indica, and ruderalis. In ancient practices, the plant was used as a multipurpose crop and valued for its fiber, food, and medicinal uses. Since methodologies for the extraction, processing, and identification of components have become available, medical, and food applications have been increasing, allowing potential development in the pharmaceutical and healthy functional food industries. Although the growing legalization and adoption of cannabis for the treatment of diseases are key factors pushing the growth of its market, the biggest challenge is to obtain higher-quality products in a time- and cost-effective fashion, making the process of extraction and separation an essential step. Latin American countries exhibit great knowledge of extraction technologies; nevertheless, it is still necessary to verify whether production costs are economically profitable. In addition, there has been an increase in commercial cannabis products that may or may not be allowed, with or without quality fact sheets, which can pose health risks. Hence, legalization is mandatory and urgent for the rest of Latin American countries. In this article, the phytochemical compounds (cannabinoids, terpenes, and phenolic compounds), the current status of legalization, extraction techniques, and research advances in cannabis in Latin America are reviewed.

Indexed as

CannabinoidsCannabisHallucinogensCannabinoid Receptor AgonistsLatin AmericaTerpenesCannabinoid Receptor AgonistsCannabinoidsHallucinogensTerpenescannabinoidsCannabisextraction proceduresvalue-added

Identifiers

PMID37049659
PMCPMC10095677
OpenAlexW4360864214

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.